Skip to main content
. 2023 Dec 13;38(1):102–110. doi: 10.1111/jvim.16970

FIGURE 5.

FIGURE 5

Basal glucose and insulin concentrations evaluated before frequently sampled intravenous glucose tolerance test at timepoint 3 (FSIGTT 3) after 7 days of dexamethasone (experimentally induced insulin dysregulation) plus 7 days of treatment: resveratrol (RES), resveratrol/aspirin (RES/ASP), metformin/aspirin (MET/ASP), resveratrol/metformin/aspirin (RES/MET/ASP), and control (CON). There were no significant differences in basal insulin or glucose concentrations. Error bars represent mean plus 95% confidence interval.